Biblio
Generation of the induced pluripotent stem cell line (NCKDi004-A) from a 17-year-old patient with Alport syndrome carring a homozygous mutation in COL4A3 gene. Stem Cell Res. 2021;56:102557.
. Identification of SRSF3 target mRNAs using inducible TRIBE. Biochem Biophys Res Commun. 2021;578:21-27.
. Construction of induced pluripotent stem cell line (ZZUi0017-A) from the fibroblast cells of a female patient with CACNA1A mutation by unintegrated reprogramming approach. Stem Cell Res. 2020;48:101946.
Generation of induced pluripotent stem cell line (NCKDi001-A) from a 19-year-old patient with a novel COL4A5 gene mutation in Alport syndrome. Stem Cell Res. 2020;49:102023.
. Generation of the human induced pluripotent stem cell line (ZJUi005-A) from a patient with Pelizaeus-Merzbacher disease (PMD) carrying a novel hemizygous mutation in PLP1 gene. Stem Cell Res. 2020;45:101791.
Single cell transcriptomic analysis reveals BCMA CAR-T cell dynamics in a patient with refractory primary plasma cell leukemia. Mol Ther. 2020.
Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells. iScience. 2020;23(6):101162.
Calcium: A New Guardian of Naive Pluripotency. Cell Stem Cell. 2019;25(2):169-170.
. Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene. Stem Cell Res. 2019;35:101395.
. Generation of induced pluripotent stem cell line (ZZUi0014-A) from a patient with spinocerebellar ataxia type 3. Stem Cell Res. 2019;41:101564.
GNAS knockdown suppresses osteogenic differentiation of mesenchymal stem cells via activation of Hippo signaling pathway. J Cell Physiol. 2019.
. Immune imbalance is associated with the development of preeclampsia. Medicine (Baltimore). 2019;98(14):e15080.
. Generation of induced pluripotent stem cell line (ZZUi0013-A) from a 65-year-old patient with a novel MEOX2 gene mutation in Alzheimer's disease. Stem Cell Res. 2018;34:101366.
. Generation of induced pluripotent stem cell line(ZZUi006-A)from a patient with myotonic dystrophy type 1. Stem Cell Res. 2018;32:61-64.
A novel Lipidoid-MicroRNA formulation promotes calvarial bone regeneration. Biomaterials. 2018;177:88-97.
Extramedullary Involvement of Mast Cell Leukemia Detected by 18F-FDG PET/CT. Clin Nucl Med. 2016.
. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J. 2016;35(8):899.
. Hyperlipidemia compromises homing efficiency of systemically transplanted BMSCs and inhibits bone regeneration. Int J Clin Exp Pathol. 2014;7(4):1580-7.
. .